Zacks.com users have recently been watching Southern Co. (SO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Gladstone Commercial (GOOD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

HCI Group (HCI) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Kilroy Realty Corporation's shares have underperformed due to higher interest rates and a challenging office leasing environment, especially in California's tech-heavy markets. Declining occupancy rates and deflationary pressures on rents, particularly in San Francisco, are expected to continue impacting Kilroy's financial performance through 2026. Despite a 6% dividend yield and solid dividend coverage, shrinking cash flow and higher debt costs make Kilroy Realty shares unattractive.

The U.S. cannabis industry continues expanding, creating opportunities for real estate investment trusts (REITs) that finance dispensaries and cultivation facilities. The legal cannabis market is projected to reach $41.5 billion by 2025, growing at a rapid pace. Currently, 38 states allow medical marijuana, while 24 states have legalized recreational use. This expansion fuels demand for real estate, making cannabis REITs essential for industry growth. Recent legalization efforts in Florida and Pennsylvania could further boost the market. However, federal cannabis reform remains uncertain, causing volatility in cannabis-related stocks. Investors must carefully analyze market conditions before making decisions.

Digital titans including Facebook and TikTok formally pledged to ramp up the fight against disinformation in the EU, Brussels said on Thursday, just days after the new US administration condemned the bloc's online content rules.

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Nextracker Inc. ("Nextracker" or the "Company") (NASDAQ:NXT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Caribou Biosciences, Inc. ("Caribou" or the "Company") (NASDAQ:CRBU) and certain officers. The class action, filed in the United States District Court for the Northern District of California, and docketed under 24-cv- 09413 is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Caribou securities between July 14, 2023 and July 16, 2024, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of …

NEW YORK CITY, NY / ACCESS Newswire / February 13, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Transocean Ltd.("Transocean" or the "Company") (NYSE:RIG).

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against GSK plc ("GSK" or the "Company") (NYSE:GSK). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Monolithic Power Systems, Inc. ("Monolithic" or the "Company") (NASDAQ:MPWR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company") (NASDAQ:REGN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Pacira Biosciences, Inc. ("Pacira" or the "Company") (NASDAQ:PCRX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Olin Corporation ("Olin" or "the Company") (NYSE:OLN). Investors who purchased Olin securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/OLN.

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Grocery Outlet Holding Corp. ("Grocery Outlet" or the "Company") (NASDAQ:GO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Crocs, Inc. ("Crocs" or the "Company") (NASDAQ:CROX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

NEW YORK CITY, NY / ACCESS Newswire / February 13, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Novo Nordisk A/S ("Novo" or the "Company") (NASDAQ:NVO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

NEW YORK CITY, NY / ACCESS Newswire / February 13, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Integral Ad Science Holding Corp. ("IAS" or the "Company") (NASDAQ:IAS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against TELUS International (Cda) Inc. ("Telus" or the "Company") (NYSE:TIXT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Polestar Automotive Holding UK PLC ("Polestar" or the "Company") (NASDAQ:PSNY). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.